Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

I Haddad, Robert; Bischoff, Lindsay; Ball, Douglas; Bernet, Victor; Blomain, Erik; Lamki Busaidy, Naifa; Campbell, Michael; Dickson, Paxton; Duh, Quan-Yang; Ehya, Hormoz; S. Goldner, Whitney; Guo, Theresa; Haymart, Megan; Holt, Shelby; P. Hunt, Jason; Iagaru, Andrei; Kandeel, Fouad; M. Lamonica, Dominick; Mandel, Susan; Markovina, Stephanie; McIver, Bryan; D. Raeburn, Christopher; Rezaee, Rod; A. Ridge, John; Y. Roth, Mara; P. Scheri, Randall; P. Shah, Jatin; A. Sipos, Jennifer; Sippel, Rebecca; Sturgeon, Cord; N. Wang, Thomas; J. Wirth, Lori; J. Wong, Richard; Yeh, Michael; J. Cassara, Carly; Darlow, Susan

doi:10.6004/jnccn.2022.0040

Public

Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Shared by NobleBlocks on Aug 1, 2022 • 12:00 AM UTC

Authors:

Robert I Haddad

Lindsay Bischoff

Douglas Ball

Abstract

Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation (iodine-131) in select patients and thyroxine therapy in most patients. Surgery is also the main treatment for...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!